Klivira
Request demo

Streamlining Humana Rexulti Prior Authorization Workflows

Klivira streamlines the complex process of obtaining Humana Rexulti prior authorization, integrating directly with payer systems to accelerate approvals for this high-volume medication.

For revenue cycle directors and prior authorization coordinators, managing prior authorizations for high-volume medications like Rexulti under Humana plans presents significant operational challenges. Understanding Humana's specific submission channels, policy requirements, and electronic PA capabilities is crucial for minimizing delays and denials. Klivira automates these critical steps, enhancing efficiency and compliance.

Understanding Rexulti's Prior Authorization Context

Rexulti (brexpiprazole) is an atypical antipsychotic medication often targeted for prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans. Its high utilization volume necessitates robust, efficient PA processes to ensure timely patient access and reduce administrative burden on clinics and health systems.

Humana's Prior Authorization Submission Channels

Humana accepts prior authorization requests through several established channels, critical for managing medications like Rexulti. For medical benefit PAs, many provider workflows are routed through Availity Essentials, which serves as the primary portal for initiation, eligibility checks, and document uploads. Additionally, X12 278 transactions are supported via clearinghouses, offering an electronic pathway for efficient data exchange.

Pharmacy Benefit PA for Rexulti under Humana

  • **Retail Pharmacy:** Submissions route through Humana's pharmacy benefit operations, leveraging ePA platforms like CoverMyMeds and Surescripts for prescriber-initiated workflows.
  • **Mail-Order/Home Delivery:** Humana's in-house pharmacy services, CenterWell Pharmacy (formerly Humana Pharmacy), manage mail-order and home-delivery prescriptions.
  • **Specialty Medications:** CenterWell Specialty Pharmacy handles specialty injectables and complex medications on the pharmacy benefit, which may apply to certain therapeutic categories similar to Rexulti.

Accessing Humana's Utilization Management Policies

Humana publishes its medical-policy and coverage-determination documents on its provider site. For Medicare Advantage lines, which constitute a significant portion of Humana's enrollment, coverage policies must align with CMS National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). Klivira integrates with these policy libraries to inform PA submission strategies, ensuring requests meet documented criteria, whether Humana-developed, MCG-based, or NCCN-compendium-based.

Navigating Humana PA Turnaround Times and CMS-0057-F

Humana publishes precertification turnaround commitments on its provider site. For Medicare Advantage organization determinations, statutory timeframes historically allowed 14 calendar days for standard pre-service decisions and 72 hours for expedited. CMS-0057-F, applicable to Humana's Medicare Advantage lines, further tightens these for impacted payers to 7 calendar days for standard prior authorizations and 72 hours for expedited requests, with phased compliance through 2027. Klivira's automation helps track these critical deadlines.

Common Denial Reasons and Appeal Pathways for Humana PAs

Denials for medications like Rexulti from Humana are typically returned via X12 277/835 transactions or portal status updates. Common reasons include medical necessity, insufficient documentation, NCD/LCD non-coverage for MA lines, or failure to meet step therapy requirements. Humana outlines its appeal pathway in its provider manual; for Medicare Advantage, this follows the CMS-mandated 5-level appeal structure for organization determinations.

Frequently asked questions

How do I submit a prior authorization for Rexulti to Humana?

For medical benefit PAs, many providers use the Availity Essentials portal. For pharmacy benefit PAs, submissions route through Humana's pharmacy benefit operations, often utilizing ePA platforms like CoverMyMeds or Surescripts for prescriber-initiated requests. X12 278 transactions are also supported for medical PAs.

Where can I find Humana's medical policies or coverage criteria for Rexulti?

Humana publishes its medical-policy and coverage-determination documents on its provider site. For Medicare Advantage plans, these policies must adhere to applicable CMS National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). Always reference the specific policy number and effective date.

What are the typical turnaround times for Humana prior authorizations?

Humana publishes precertification turnaround commitments on its provider site. For Medicare Advantage, CMS-0057-F mandates 7 calendar days for standard prior authorizations and 72 hours for expedited requests for impacted payers like Humana, with compliance phasing in through 2027.

Does Humana support electronic prior authorization (ePA) for medications like Rexulti?

Yes, Humana participates in the HL7 Da Vinci Project ecosystem, and for pharmacy benefits, ePA is supported through platforms like CoverMyMeds and Surescripts. Medical benefit ePA depends on the specific procedure category and partner-vendor configurations.

What are common reasons for Humana to deny a prior authorization for Rexulti?

Common denial reasons include lack of medical necessity, insufficient documentation, non-adherence to NCD/LCD for Medicare Advantage plans, or failure to meet step therapy requirements. Denials are typically communicated via X12 277/835 transactions or portal status updates.

Related coverage

Other rexulti prior authorization by payer

Other rexulti prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo